FactSet posts strong Q1 results with 6.9% revenue growth
FactSet (NYSE:FDS) reported solid first-quarter results for fiscal 2026, with GAAP revenues rising 6.9% year-over-year to $607.6 million, and organic revenues increasing 6% to $600 million.
Todas as matérias desta categoria, das mais recentes às mais antigas.
FactSet (NYSE:FDS) reported solid first-quarter results for fiscal 2026, with GAAP revenues rising 6.9% year-over-year to $607.6 million, and organic revenues increasing 6% to $600 million.
Optical Cable Corporation (NASDAQ:OCC) today reported strong results for fiscal 2025, showing a significant improvement in profitability despite a slight dip in net sales.
For the year ended October 31, 2025, the company saw gross profit rise by 24.1%, reaching $22.6 million, and gross margin increase to 30.9% from 27.3% in fiscal 2024.
Trump Media & Technology Group (NASDAQ:DJT) and TAE Technologies have announced a landmark merger valued at over $6 billion, positioning the combined entity as one of the first publicly traded companies in the burgeoning fusion energy sector.
Uxin (NASDAQ:UXIN), a leading Chinese online used car platform, announced impressive financial results for the third quarter of fiscal 2025, reporting a substantial 76.8% year-over-year increase in total revenue.
The European Medicines Agency (EMA) has officially validated the marketing authorization application for DATROWAY® (datopotamab deruxtecan), a novel antibody-drug conjugate (ADC), for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not eligible for PD-1/PD-L1 inhibitors.
Takeda Pharmaceutical Company (NYSE:TAK) has announced positive topline results from its two pivotal Phase 3 trials evaluating zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis.
US stocks slid after delayed shutdown-era jobs data showed rising unemployment, while bitcoin climbed in a fresh sign of its growing divergence from traditional markets.
Ripple is celebrating the rapid ascent of its RLUSD stablecoin into the top tier of regulated USD tokens, underscoring strong institutional adoption, regulatory alignment and growing global integration.
Former Alameda Research chief executive Caroline Ellison has been transferred from federal prison to a reentry facility ahead of an early release, highlighting her cooperation in the FTX case and renewed public attention on the exchange’s collapse.
VYNE Therapeutics (NASDAQ:VYNE) and Yarrow Bioscience have entered into a definitive all-stock merger agreement, with the combined company expected to operate under the name Yarrow Bioscience and trade on Nasdaq under the ticker YARW.
ABM Industries (NYSE:ABM) reported a fiscal fourth-quarter net income of $34.8 million, or 56 cents per share, recovering from a loss in the same period last year.
However, the company’s adjusted earnings, which exclude restructuring costs and expenses related to mergers and acquisitions, were 88 cents per share, missing Wall Street expectations.
General Mills (NYSE:GIS) reported its second-quarter results for the fiscal year 2025, showing a 7 percent decrease in net sales to $4.9 billion
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade